Quotient Limited (QTNT) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
28 ESPLANADE SAINT HELIER, JE2 3QA |
| State of Incorp. | |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2022 | 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments, including: | 67,685 | 103,800 | 111,700 | 120,800 | 94,800 | 25,500 | ||
| Cash and cash equivalents | 65,059 | 85,060 | 45,673 | 3,923 | 4,096 | 20,165 | ||
| Short-term investments | 2,626 | 18,719 | 65,999 | 116,871 | 90,729 | 5,669 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | 21 | 28 | 6 | (25) | (334) | |||
| Restricted cash and investments | 320 | |||||||
| Receivables | 6,272 | 6,146 | 5,323 | 5,402 | 3,348 | 2,862 | ||
| Inventory, net of allowances, customer advances and progress billings | 22,036 | 22,759 | 22,011 | 20,501 | 15,551 | 16,278 | ||
| Inventory | 22,036 | 22,759 | 22,011 | 20,501 | 15,551 | 16,278 | ||
| Other undisclosed current assets | 5,761 | 6,750 | 4,842 | 3,769 | 3,227 | 7,079 | ||
| Total current assets: | 101,754 | 139,455 | 143,876 | 150,472 | 116,926 | 52,039 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 29,411 | 20,405 | 22,011 | 21,493 | ✕ | ✕ | ||
| Property, plant and equipment | 33,242 | 34,950 | 39,071 | 40,165 | 47,293 | 60,156 | ||
| Long-term investments and receivables | 15,467 | |||||||
| Long-term investments | 15,467 | |||||||
| Intangible assets, net (including goodwill) | 520 | 553 | 619 | 625 | 751 | 914 | ||
| Intangible assets, net (excluding goodwill) | 520 | 553 | 619 | 625 | 751 | 914 | ||
| Restricted cash and investments | 8,744 | 8,309 | 9,024 | 9,017 | 7,507 | |||
| Deferred income tax assets | 123 | 240 | 255 | 237 | ✕ | ✕ | ||
| Other noncurrent assets | 4,728 | 4,864 | 4,956 | 4,454 | 4,688 | 5,043 | ||
| Other undisclosed noncurrent assets | 605 | 5,689 | ||||||
| Total noncurrent assets: | 92,235 | 69,321 | 75,936 | 75,991 | 60,844 | 71,802 | ||
| TOTAL ASSETS: | 193,989 | 208,776 | 219,812 | 226,463 | 177,770 | 123,841 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 28,563 | 20,332 | 29,810 | 26,532 | 23,742 | 23,227 | ||
| Accounts payable | 5,828 | 5,613 | 6,381 | 6,550 | 7,273 | 6,713 | ||
| Accrued liabilities | 4,997 | 3,532 | 3,077 | 4,423 | 3,692 | 6,590 | ||
| Employee-related liabilities | 8,503 | 7,155 | 12,343 | 7,210 | 6,149 | 5,312 | ||
| Taxes payable | 293 | |||||||
| Interest and dividends payable | 9,235 | 4,032 | 8,009 | 8,056 | 6,628 | 4,612 | ||
| Debt | 537 | 617 | 25,002 | 3,631 | 471 | 515 | ||
| Deferred rent credit | 435 | ✕ | ||||||
| Other undisclosed current liabilities | 3,728 | 3,226 | 4,647 | 994 | 801 | 3,309 | ||
| Total current liabilities: | 32,828 | 24,175 | 59,459 | 31,157 | 25,449 | 27,051 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 29,141 | 20,501 | 21,352 | 166,031 | 120,865 | 85,422 | ||
| Long-term debt, excluding current maturities | 145,000 | 120,000 | 84,000 | |||||
| Finance lease, liability | 388 | 408 | 445 | 1,117 | ✕ | ✕ | ||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | 865 | 1,422 | ||
| Operating lease, liability | 28,753 | 20,093 | 20,907 | 19,914 | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 42,805 | 61,040 | 29,523 | 26,778 | 27,887 | 6,168 | ||
| Deferred rent credit | 1,144 | ✕ | ||||||
| Deferred income tax liabilities | 1,988 | 2,216 | 1,152 | ✕ | ✕ | |||
| Liability, pension and other postretirement and postemployment benefits | 4,777 | 7,577 | 6,896 | 6,353 | 7,368 | 6,168 | ||
| Financial instruments subject to mandatory redemption, settlement terms, share value, amount | 22,525 | 22,263 | 21,475 | 20,425 | 19,375 | |||
| Derivative instruments and hedges, liabilities | 13,515 | 28,984 | ||||||
| Other undisclosed noncurrent liabilities | 233,313 | 228,670 | 145,059 | 8,024 | 1,855 | 19,831 | ||
| Total noncurrent liabilities: | 305,259 | 310,211 | 195,934 | 200,833 | 150,607 | 111,421 | ||
| Total liabilities: | 338,087 | 334,386 | 255,393 | 231,990 | 176,056 | 138,472 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (144,098) | (125,610) | (35,581) | (5,527) | 1,714 | (14,631) | ||
| Common stock | 540,736 | 540,732 | 540,813 | 459,931 | 368,958 | |||
| Additional paid in capital | 46,399 | 45,117 | 38,116 | 33,132 | 28,665 | 23,708 | ||
| Accumulated other comprehensive loss | (6,191) | (12,329) | (14,598) | (15,155) | (14,884) | (16,634) | ||
| Accumulated deficit | (725,042) | (699,130) | (599,912) | (483,435) | (381,025) | (275,639) | ||
| Other undisclosed stockholders' equity attributable to parent | 253,934 | |||||||
| Total stockholders' equity: | (144,098) | (125,610) | (35,581) | (5,527) | 1,714 | (14,631) | ||
| TOTAL LIABILITIES AND EQUITY: | 193,989 | 208,776 | 219,812 | 226,463 | 177,770 | 123,841 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 3/31/2022 | 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 38,514 | 37,817 | 43,379 | 32,656 | 29,134 | 24,732 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 24,732 | |
| Cost of revenue | (23,569) | (22,870) | (20,074) | (17,800) | (17,230) | (10,471) | |
| Other undisclosed gross profit | (1) | ||||||
| Gross profit: | 14,944 | 14,947 | 23,305 | 14,856 | 11,904 | 14,261 | |
| Operating expenses | (118,771) | (113,887) | (106,002) | (95,547) | (90,859) | (84,249) | |
| Operating loss: | (103,827) | (98,940) | (82,697) | (80,691) | (78,955) | (69,988) | |
| Nonoperating expense | (20,342) | (23,659) | (27,081) | (21,421) | (26,387) | (12,999) | |
| Other nonoperating income (expense) | 11,612 | (1,114) | 2,723 | 2,438 | (6,369) | 2,366 | |
| Interest and debt expense | (147) | (12,965) | (7,043) | (5,908) | (4,359) | ||
| Loss from continuing operations before equity method investments, income taxes: | (124,316) | (122,599) | (122,743) | (109,155) | (111,250) | (87,346) | |
| Other undisclosed income from continuing operations before income taxes | 147 | 12,965 | 7,043 | 5,908 | 4,359 | ||
| Loss from continuing operations before income taxes: | (124,169) | (122,599) | (109,778) | (102,112) | (105,342) | (82,987) | |
| Income tax expense (benefit) | (961) | (1,017) | (1,254) | (661) | (44) | 649 | |
| Net loss available to common stockholders, basic: | (125,130) | (123,616) | (111,032) | (102,773) | (105,386) | (82,338) | |
| Other undisclosed net loss available to common stockholders, diluted | (6,753) | ||||||
| Net loss available to common stockholders, diluted: | (125,130) | (130,369) | (111,032) | (102,773) | (105,386) | (82,338) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2022 | 12/31/2021 TTM | 3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (125,130) | (123,616) | (111,032) | (102,773) | (105,386) | (82,338) | |
| Other comprehensive income (loss) | 8,407 | 2,268 | (1,926) | (271) | 1,750 | 2,658 | |
| Comprehensive loss, net of tax, attributable to parent: | (116,723) | (121,348) | (112,958) | (103,044) | (103,636) | (79,680) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.